Stock DNA
Pharmaceuticals & Biotechnology
VND 76,500 Million (Micro Cap)
8.00
NA
0.00%
-0.21
10.48%
0.79
Revenue and Profits:
Net Sales:
33,826 Million
(Quarterly Results - Jun 2025)
Net Profit:
2,269 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
59.38%
0%
59.38%
6 Months
57.73%
0%
57.73%
1 Year
66.3%
0%
66.3%
2 Years
62.77%
0%
62.77%
3 Years
39.09%
0%
39.09%
4 Years
10.87%
0%
10.87%
5 Years
-41.15%
0%
-41.15%
Cai Lay Veterinary Pharmaceutical JSC for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
5.13%
EBIT Growth (5y)
12.12%
EBIT to Interest (avg)
70.52
Debt to EBITDA (avg)
0.36
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
1.34
Tax Ratio
20.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
15.78%
ROE (avg)
9.28%
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
0.54
EV to EBIT
2.64
EV to EBITDA
1.92
EV to Capital Employed
0.41
EV to Sales
0.23
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
15.51%
ROE (Latest)
6.93%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
33,826.40
33,412.40
1.24%
Operating Profit (PBDIT) excl Other Income
4,814.90
4,073.80
18.19%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
2,269.20
1,957.90
15.90%
Operating Profit Margin (Excl OI)
111.50%
90.70%
2.08%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 1.24% vs 20.68% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 15.90% vs 671.74% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
107,036.50
110,905.50
-3.49%
Operating Profit (PBDIT) excl Other Income
16,290.40
17,863.40
-8.81%
Interest
38.50
481.40
-92.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
7,324.30
6,201.50
18.11%
Operating Profit Margin (Excl OI)
112.70%
96.40%
1.63%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -3.49% vs -7.30% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 18.11% vs 5.04% in Dec 2023
About Cai Lay Veterinary Pharmaceutical JSC 
Cai Lay Veterinary Pharmaceutical JSC
Pharmaceuticals & Biotechnology
Cai Lay Veterinary Pharmaceutical Joint Stock Company is a Vietnam-based pharmaceutical company. It is engaged in the manufacture and trading of medicine and veterinary pharmaceutical products. The Company also manufactures and trades nutrition and feedstuff for animals. It is involved in the retail of drugs, medical equipment, cosmetics and sanitary products in specialized shops. In addition, the Company is involved in aquaculture and fishing activities, agricultural and forestry product processing, seafood trading, wood processing and the manufacture of wood furniture and other products for outdoor and indoor decoration purposes. It also trades breeding plants and fertilizers. The Company announces that AUSTFEED Vietnam Joint Stock Co has acquired 1,059,983 shares in the Company on February 22, 2013, raising its stake in the Company from 17.77% to 57.19%.
Company Coordinates 
Company Details
Khu pho 1, phuong 5, thi xa Cai Lay , TIEN GIANG None : None
Registrar Details






